MediWound Ltd.
General ticker "MDWD" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $196.5M (TTM average)
MediWound Ltd. follows the US Stock Market performance with the rate: 22.0%.
Estimated limits based on current volatility of 2.1%: low 17.35$, high 18.09$
Factors to consider:
- Total employees count: 63 as of 2014
- Price in estimated range
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [10.29$, 23.20$]
- 2025-12-31 to 2026-12-31 estimated range: [8.68$, 20.15$]
Financial Metrics affecting the MDWD estimates:
- Negative: with PPE of -7.3 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -7.81 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: 41.86 < Shareholder equity ratio, % of 42.39 <= 63.39
- Positive: Interest expense per share per price, % of 0.43 <= 0.79
- Positive: Inventory ratio change, % of -1.42 <= -0.75
Short-term MDWD quotes
Long-term MDWD plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $26.50MM | $18.69MM | $20.22MM |
| Operating Expenses | $34.84MM | $33.98MM | $39.62MM |
| Operating Income | $-8.35MM | $-15.29MM | $-19.40MM |
| Non-Operating Income | $-11.18MM | $8.76MM | $-10.76MM |
| Interest Expense | $0.16MM | $0.34MM | $0.75MM |
| R&D Expense | $10.18MM | $7.47MM | $8.88MM |
| Income(Loss) | $-19.52MM | $-6.53MM | $-30.16MM |
| Taxes | $0.08MM | $0.18MM | $0.06MM |
| Profit(Loss)* | $-19.60MM | $-6.72MM | $-30.22MM |
| Stockholders Equity | $10.91MM | $31.59MM | $31.15MM |
| Inventory | $1.96MM | $2.85MM | $2.69MM |
| Assets | $50.02MM | $66.46MM | $73.50MM |
| Operating Cash Flow | $-11.88MM | $-10.46MM | $-13.62MM |
| Capital expenditure | $0.56MM | $6.46MM | $6.27MM |
| Investing Cash Flow | $-0.48MM | $-34.32MM | $-8.40MM |
| Financing Cash Flow | $35.76MM | $22.92MM | $19.39MM |
| Earnings Per Share** | $-3.93 | $-0.75 | $-3.03 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.